Glucosamine-6-phosphate synthase from Escherichia coli: determination of the mechanism of inactivation by N3-fumaroyl-L-2,3-diaminopropionic derivatives.

A mechanistic investigation of the inactivation of Escherichia coli glucosamine-6-phosphate synthase by N3-(4-methoxyfumaroyl)-L-2,3-diaminopropionate (FMDP) was undertaken. On the basis of the known participation of the N-terminal cysteine residue in this process [Chmara et al. (1986) Biochim. Biophys. Acta 870, 357; Badet et al. (1988) Biochemistry 27, 2282], the model reactions between FMDP and L-cysteine and between FMDP and the synthetic decapeptide Cys-Gly-Ile-Val-Gly-Ala-Ile-Ala-Gln-Arg, corresponding to the amino-terminal protein sequence, were studied. The results allowed us to propose a pathway that is in perfect agreement with the biochemical results: enzyme inactivation arose from Michael addition of glutamine binding site cysteine-1 on the fumaroyl double bond at the beta-position of the ester group. Upon denaturation under slightly alkaline conditions, this adduct underwent cyclization to a transient succinimide adduct, which rearranged into the stable 2-substituted 1,4-thiazin-3-one-5-carboxylate involving participation of the cysteine amino group. The tryptic radiolabeled peptides purified from [3H]FMDP-treated enzyme and resistant to Edman degradation coeluted with the products resulting from the model reaction between the synthetic decapeptide and the inhibitor.

[1]  B. Badet,et al.  Quantitative Synthesis of L Or D N2-Tertbutoxycarbonyl- 2,3-DIAMINOPROPANOIC ACID FROM PROTECTED L OR D SERINE-β -LACTONE , 1989 .

[2]  G. Jung,et al.  Chlorotetain from Bacillus subtilis, an Antifungal Dipeptide with an Unusual Chlorine‐containing Amino Acid , 1988 .

[3]  D. Rich,et al.  Irreversible inhibition of papain by epoxysuccinyl peptides. Carbon-13 NMR characterization of the site of alkylation , 1988 .

[4]  B. Badet,et al.  Glucosamine synthetase from Escherichia coli: kinetic mechanism and inhibition by N3-fumaroyl-L-2,3-diaminopropionic derivatives. , 1988, Biochemistry.

[5]  G. Rankin,et al.  Cyclization of a cysteine conjugate of N‐(3,5‐Dichlorophenyl)succinimide , 1988 .

[6]  D. Loebenberg,et al.  Sch 37137, a novel antifungal compound produced by a Micromonospora sp. Taxonomy, fermentation, isolation, structure and biological properties. , 1988, The Journal of antibiotics.

[7]  T. Satoda,et al.  Diaminopropionate ammonia-lyase from Salmonella typhimurium. Purification and characterization of the crystalline enzyme, and sequence determination of the pyridoxal 5'-phosphate binding peptide. , 1988, The Journal of biological chemistry.

[8]  E. Borowski,et al.  Antifungal peptides with novel specific inhibitors of glucosamine 6-phosphate synthase. , 1988, Drugs under experimental and clinical research.

[9]  F. Lederer,et al.  Glucosamine synthetase from Escherichia coli: purification, properties, and glutamine-utilizing site location. , 1987, Biochemistry.

[10]  D. Stevens.  Problems in Antifungal Chemotherapy , 1987, Infection.

[11]  B. Dupont,et al.  Evolution of antifungal agents: past, present, and future. , 1987, Reviews of infectious diseases.

[12]  E. Borowski,et al.  Synthesis of N3-fumaramoyl-L-2,3-diaminopropanoic acid analogues, the irreversible inhibitors of glucosamine synthetase. , 1986, International journal of peptide and protein research.

[13]  E. Borowski,et al.  Inactivation of glucosamine-6-phosphate synthetase from Salmonella typhimurium LT2 by fumaroyl diaminopropanoic acid derivatives, a novel group of glutamine analogs. , 1986, Biochimica et biophysica acta.

[14]  E. Borowski,et al.  Anticapsin: an active site directed inhibitor of glucosamine-6-phosphate synthetase from Candida albicans. , 1986, Drugs under experimental and clinical research.

[15]  E. Borowski,et al.  Synthetic derivatives of N3-fumaroyl-L-2,3-diaminopropanoic acid inactivate glucosamine synthetase from Candida albicans. , 1985, Biochimica et biophysica acta.

[16]  H. Chmara.  Inhibition of glucosamine synthase by bacilysin and anticapsin. , 1985, Journal of general microbiology.

[17]  W. Müller,et al.  Synthese von N‐Maleoyl‐aminosäuren und ‐peptiden , 1985 .

[18]  H. Zalkin.  [32] Glutamine amidotransferases , 1985 .

[19]  E. Borowski,et al.  Anticandidal activity of antibiotic A 19009 and its isomer. , 1984, The Journal of antibiotics.

[20]  C. Walsh,et al.  Inactivation of the dadB Salmonella typhimurium alanine racemase by D and L isomers of beta-substituted alanines: kinetics, stoichiometry, active site peptide sequencing, and reaction mechanism. , 1984, Biochemistry.

[21]  E. Borowski,et al.  Inactivation of glucosamine-6-phosphate synthetase from Salmonella typhimurium LT 2 SL 1027 by N beta-fumarylcarboxyamido-L-2,3-diamino-propionic acid. , 1984, Biochemical and biophysical research communications.

[22]  M. Kenig,et al.  The mode of action of bacilysin and anticapsin and biochemical properties of bacilysin-resistant mutants. , 1976, Journal of general microbiology.

[23]  M. Gorman,et al.  A new dipeptide antibiotic from Streptomyces collinus, Lindenbein. , 1972, The Journal of antibiotics.

[24]  J. Walker,et al.  Isolation of bacilysin and a new amino acid from culture filtrates of Bacillus subtilis. , 1970, The Biochemical journal.